Safilo Group (SFL) Fair Value & Analysis
Healthcare · IT · Market cap €740M
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 5 days ago
Share price +4.2% over the past month.
Price vs Fair Value (12 months)
12‑month range €0.8671 – €2.19 · fair‑value band €1.71 – €2.98 · the €1.70 price screens below the €2.19 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Safilo Group (SFL) currently trades at €1.70, while our model-based Fair Value estimate is €2.19 — implying the stock looks roughly 28.6% undervalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Safilo Group generated revenue of €983M at a net margin of 5.0%. Revenue declined 3.4% year over year. It earns a return on equity of 11.6%. Net debt stands at €6.6M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Safilo Group S.p.A., together with its subsidiaries, designs, manufactures, and distributes optical frames, sunglasses, sports eyewear, goggles, and helmets in North America, Europe, the Asia Pacific, and internationally. The company offers fashion items under the Boss, Carolina Herrera, Dsquared2, Etro, Isabel Marant, Missoni, Moschino, PORTS, and Victoria Beckham brand names; lifestyle products under the Carrera, Eyewear by David Beckham, Marc Jacobs, Levi's, Tommy Hilfiger, Tommy Jeans, Kate Spade New York, Kurt Geiger, Fossil, HUGO, Juicy Couture, Liz Claiborne, Love Moschino, Pierre Cardin, and Stuart Weitzman brand names; sports and outdoor items under the Smith and Under Armour brand names; and mass cool products under the Blenders, Polaroid, Privé Revaux, and Seventh Street brand names. It sells its products to opticians, optometrists, ophthalmologists, retail chains, department stores, specialty retailers, boutiques, duty free, and sports stores through a network of indepen…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Safilo Group reported revenue of €983M in FY2025 versus €970M in FY2021, a compound +0.4%/yr. Reported net income was €48.6M in FY2025, compounding +23.0%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $412.02 | $165.35 | -60% |
| EssilorLuxottica Société anonyme ESLOF | $190.25 | $125.65 | -34% |
| HOYA Corporation HOCPY | $168.16 | $96.16 | -43% |
| Medline Inc MDLN | $34.71 | $30.15 | -13% |
| Becton, Dickinson and Company BDX | $149.56 | $117.04 | -22% |
| Alcon Inc ALC | $66.58 | $36.99 | -44% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Safilo Group (SFL) undervalued?
What is the fair value of SFL?
What is the quality score of SFL?
What is the revenue of Safilo Group (SFL)?
What is the net profit margin of SFL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.